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more attention should be paid to patients’ views to increase treatment
adherence.
Qualitative studies have also permitted to better understand differences
in access to total knee or hip arthroplasties among patients with knee
or hip OA and motives of satisfaction or dissatisfaction of patients after
these surgical interventions.
Finally, qualitative research will probably lead to consider concepts
differing from disability or HRQoL such as expectations, needs, fears
and beliefs and help to develop accurate measure tools to assess these
concepts.
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THE ROLE OF MIR-140 IN OA PATHOGENESIS
H. Asahara1,2. 1The Scripps Res. Inst., La Jolla, CA, USA; 2Tokyo Med. and
Dental Univ. and Natl. Res. Inst. for Child Hlth.and Dev., Tokyo, Japan
Purpose: Osteoarthritis (OA) is the most prevalent disorder of synovial
joints, characterized by focal areas of articular cartilage destruction.
MicroRNAs (miRNAs) are a family of ~22-nucleotide (nt) noncoding
RNAs that are evolutionarily conserved and regulate gene expression
by posttranscriptional mechanisms. miR-140 is highly expressed in
chondrocytes, however its function has not yet been elucidated.
Methods and Results: To examine the role of miR140 in vivo, we
generated miR140 null mice. During embryogenesis and at neonatal
stage, skeletal formation of miR140 null mice is not signiﬁcantly
disturbed compared with wild type mice. Postnatal growth of limbs
and body of null mice is slightly signiﬁcantly repressed compared with
wild-type.
In null miR140 mice knee articular cartilage we observed spontaneous
onset of osteoarthritis at the age of 8 months.
To test the function of miR-140 in articular cartilage, we performed
microarray for mRNA expression with articular cartilage from wild
type and miR-140 null mice and on chondrocytes transfected with
miR-140. Among the mRNAs most highly increased in miR140
null mice was ADAMTS-5, a critical cartilage degradation enzyme
in osteoarthritis pathogenesis. ADAMTS-5 is also a strong miR-140
candidate as predicted from Target scan bioinformatics data-base.
ADAMTS-5 expression is signiﬁcantly increased in chondrocytes from
miR-140 null mice. Consistent with this, GAG loss in articular cartilage
was signiﬁcantly increased in miR140 null mice. Overexpression of miR-
140 in chondrocytes from miR-140 null mice decreased the expression of
ADAMTS-5. Furthermore, reporter construct carrying ADAMTS-5 3’ UTR
was also inhibited by miR-140 overexpression.
Conclusions: These data indicate that ADAMTS-5 is directly inhibited
by miR-140 and that loss of miR-140 causes catabolic effect on cartilage
homeostasis and subsequent osteoarthritis, at least in part, via regulating
ADAMTS-5.
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HAND OA: A DISEASE IN NEED OF TREATMENT
K. Dziedzic. Arthritis Res. UK Primary Care Ctr. Keele Univ., Keele, United
Kingdom
Hand osteoarthritis is one of the commonest forms of osteoarthritis and
until recent years there has been limited research and a general feeling
that nothing can be done for people with hand OA. The talk will have
an emphasis on primary care where most people present and where
there is a gap between what patients could be offered and what patients
receive [1].
The presentation will describe hand OA not as a single disease but as
a group of complex conditions [2] ranging a syndrome of joint pain
accompanied by functional limitation, or a condition deﬁned by the
presence of features and severity of symptoms (ACR criteria) [3], to highly
characterised subsets of radiographic hand OA [4]. The presentation
in particular will draw on ﬁndings from three large cohorts of adults
50 years and over studied in the North West Midlands in the UK
(n =30,000) (Norstop1 [5], CAS-HA [6], Smooth [7]).
The prevalence of hand OA and impact on hand pain and functional
decline over three years will be described, along with consultation
for hand pain and hand OA in primary care using survey data and
consultation records. Hand OA as an important marker of OA in the
person will be highlighted.
Using OARSI recommendations for the design and conduct of trials in
hand OA [8] patients in need of treatment will be deﬁned and the uptake
of treatment by eligible individuals will be reported using a study of hand
exercises and joint protection as an example [7].
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WHAT’S WRONG WITH ANIMAL MODELS OF PAIN?
J. Mogil. McGill Univ., Montreal, QC, Canada
Recent decades have seen an explosion in our understanding of the
molecular and cellular underpinnings of pain, but virtually none of this
knowledge has resulted in new clinical therapies. Many pain researchers
believe that the problem may lie in the existing animal models of pain,
which are reliable but much more complex and subtle than is commonly
realized, and of questionable clinical relevance. Most basic science studies
of pain continue to rely on the measurement of reﬂexive, evoked
hypersensitivity responses after artiﬁcial neuropathic or inﬂammatory
injuries, whereas clinical pain in humans features much spontaneous
pain and an important cognitive and emotional overlay. In addition
to the disconnect between clinical symptoms and animal measures,
there is a disconnect between the clinical epidemiology of pain and the
types of pain being modeled in animals. We have recently attempted
to develop an “ethological” approach to animal models of common pain
pathologies, involving systematic and rigorous analysis of videotaped
spontaneous mouse behaviors. I will talk about some recent successes in
our laboratory, involving migraine, vestibulodynia, and the development
of a facial expression-based pain scale for the mouse.
